Meeting Report on an Integrated Research Agenda for Mosquito-Borne Arboviruses - Takeaways - MDSpire

Meeting Report on an Integrated Research Agenda for Mosquito-Borne Arboviruses

  • By

  • Angela K Ulrich

  • Nicolina M Moua

  • Alison Mack

  • Natsuko Imai-Eaton

  • J Erin Staples

  • Angela J Mehr

  • Julia T Ostrowsky

  • Tabitha Leighton

  • Ana Cehovin

  • Petra C Fay

  • Josephine P Golding

  • Emma Maynard

  • Luke Alphey

  • Diana P Rojas Alvarez

  • Lark L Coffey

  • Nuno R Faria

  • Rafael Maciel-de-Freitas

  • Kevin Maringer

  • Kris A Murray

  • Henrik Salje

  • Rosemary Sang

  • Pedro F C Vasconcelos

  • Yee-Sin Leo

  • Steven P Sinkins

  • Jocelyne Neto de Vasconcelos

  • Samuel K Dadzie

  • Eva Harris

  • Thais H dos Santos

  • Raman Velayudhan

  • Jurai Wongsawat

  • Michael T Osterholm

  • Eve M Lackritz

  • July 9, 2025

  • 0 min

Share

  • 1

    Mosquito-borne arbovirus diseases are a growing global health threat due to climate change, urbanization, and inadequate vector control.

  • 2

    Aedes species, particularly Ae. aegypti and Ae. albopictus, are primary vectors for significant diseases like Dengue and Zika.

  • 3

    The Wellcome Trust and CIDRAP convened experts to develop a research agenda focused on MBV disease prevention and response.

  • 4

    Recent decades have seen a dramatic increase in the incidence and geographic spread of Aedes-borne arboviral diseases.

  • 5

    Priority strategies for research and investment in MBV control emphasize an integrated approach addressing ecological and social factors.

Original Source(s)

Meeting Report on an Integrated Research Agenda for Mosquito-Borne Arboviruses

  • by Angela K Ulrich, Nicolina M Moua, Alison Mack, Natsuko Imai-Eaton, J Erin Staples, Angela J Mehr, Julia T Ostrowsky, Tabitha Leighton, Ana Cehovin, Petra C Fay, Josephine P Golding, Emma Maynard, Luke Alphey, Diana P Rojas Alvarez, Lark L Coffey, Nuno R Faria, Rafael Maciel-de-Freitas, Kevin Maringer, Kris A Murray, Henrik Salje, Rosemary Sang, Pedro F C Vasconcelos, Yee-Sin Leo, Steven P Sinkins, Jocelyne Neto de Vasconcelos, Samuel K Dadzie, Eva Harris, Thais H dos Santos, Raman Velayudhan, Jurai Wongsawat, Michael T Osterholm, Eve M Lackritz

  • July 9, 2025

Related Content

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

Congo Ebola Outbreak Strains Care Delivery

“We live with fear in our stomachs"

Influenza Vaccine and Associated Infection and Death in California, 2024 to 2025